Frontlight ResearchEarly access
Taking peopleNo phase
Recurrence of H Pylori : Incidence and Influential Factors.
Key facts
- Who runs it
- Sohag University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 13 May 2025
- Planned end
- 20 Nov 2025
- Type of study
- Interventional
- Treatments tested
- follow up of patients that had H. Pylori infection and recieved medical treatment for recurrence
- Record updated
- 1 July 2025
Who can take part
- Age
- 18 years to 75 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Age: 18-75 years old
- H. pylori infection: Confirmed by endoscopy, biopsy, or non-invasive tests (e.g., urea breath test, stool antigen test)
- Symptoms: Presence of dyspepsia, peptic ulcer disease, or other H. pylori-related symptoms
- Laboratory tests: Normal liver and kidney function, and no significant abnormalities in blood counts
Who cannot take part
- Patients receiving eradication therapy in the past taking proton pump inhibitors,, H2 blockers ,,bismuth ,, antibiotics or other medications that interfere with the result of the examination in the recent 4 weeks
- Gastrointestinal disorders: Severe gastrointestinal disorders (e.g., gastric cancer, inflammatory bowel disease ,gastric or duodenal ulcer with current or recent bleeding , or clinical significant gastrointestinal bleeding within 4 weeks of randomization)
- Malignancies: Active or recent malignancies
- Severe comorbidities: Unstable or severe comorbidities (e.g., heart failure, liver cirrhosis)
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aims to determine recurrence rates, identify influential factors, investigate key factors that contribute to recurrence, evaluate treatment effectiveness and to assess the efficacy of different eradication regimens and their role in reducing recurrence.
The group in the trial
- follow up of patients that had H. Pylori infection and recieved medical treatment for recurrenceOther group
follow up of patients that had H. Pylori infection and recieved medical treatment for recurrence and influential factors for recurrence
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Recurrence of H Pylori : Incidence and Influential Factors in Sohag Government.
- Criteria questions
- Built from NCT07045857, who can take part
- Record updated
- 1 July 2025